Video – Dispelling Sun Protection Myths & Misconceptions
With the outbreak of the COVID-19 pandemic, our movements have been restricted and 2020 has become the year of the balcony, back garden and staycation for many of us. While spending time outdoors is important for our own and our family’s physical and mental well-being, it is equally important to enjoy the sun safely and […]
Call for Access to Game-Changing Eczema Treatment on RTÉ’s Ray D’Arcy Show
Listen to the full interview Ray D’Arcy interviewed Paul Herriott, ISF Board Member, who has lived with eczema since childhood and Prof Alan Irvine, Consultant Dermatologist at St James’ Hospital and Children’s Health Ireland at Crumlin about the urgent need for access in Ireland to first-in-class drug (dupilumab), which has been available to patients elsewhere […]
ISF Calls for Access to Life-Changing Eczema Treatment
Ireland among last countries in EU to make new drug available to patients Listen to Paul Herriott and Prof Alan Irvine being interviewed on The Ray D’Arcy Show, RTÉ Radio 1 The ISF is calling on HSE management to reimburse a first-in-class drug (dupilumab) to provide access to hundreds of people living with severe […]
New Report Documents Sunburn, SunSmart Behaviours and Sunbed Use by Children in Ireland for the First Time
A new report titled, Children’s exposure to ultraviolet radiation – a risk profile for future skin cancers in Ireland, which was published on June 17th 2020, presents findings on children’s exposure to ultraviolet (UV) radiation from the sun and sunbeds, UV skin protection behaviours, and sunburn. High-risk groups: children and young people The report was […]
Is it true? Will sunlight really help my skin condition?
During spells of good weather and throughout the summer months, our ‘Ask a Nurse’ team are often shyly asked: “So what about the sun – I’ve heard that it’s really good for clearing psoriasis [or eczema]?” This is a fair question; who wouldn’t want to clear their skin in what appears to be a simple […]
New survey for psoriasis patients to self-report experiences of COVID-19
PsoProtectMe is a new initiative by PsoProtect for psoriasis patients to self-report their COVID-19 experience. The Irish Skin Foundation is delighted to be a partner of PsoProtect, an international registry for health care providers to report outcomes of COVID-19 in individuals with psoriasis. PsoProtect has released data from over 100 cases reported by clinicians globally, […]
The Importance of Emollient Treatment in Eczema
Atopic eczema is a very common, non-contagious, chronic inflammatory skin condition. While the exact cause is not known, certain factors are thought to be important in its development, these include an inherited predisposition to have a weakened skin barrier, as well as altered inflammatory and allergy responses. Atopic eczema most frequently begins in infancy but may […]
Covid-19 and Skin Conditions – Expert Q&A
This video was recorded on 1st April 2020 with Professor Anne-Marie Tobin, Consultant Dermatologist at Tallaght University Hospital and HSE Clinical Lead for Dermatology, and Professor Brian Kirby, Consultant Dermatologist at St Vincent’s Hospital and a global expert on psoriasis, to discuss some of the most frequently asked questions that the ISF has received in […]
ISF to join Irish Cancer Prevention Network
The Irish Skin Foundation is set to join the Irish Cancer Prevention Network (ICPN), which brings together collaborative working between organisations with the aim to reduce cancer risk for the people of Ireland. The network was established by the National Cancer Control Programme, Marie Keating Foundation, Irish Cancer Society and Breakthrough Cancer Research. The ISF […]
International registry of outcomes for COVID-19 and people living with psoriasis
ISF joins efforts to support a new international initiative, specific to psoriasis, has been set up as response to the COVID-19 pandemic PsoProtect is an international registry (i.e. a sophisticated database that will provide a real-world view health information like clinical practice, patient outcomes, safety, and comparative effectiveness) for health care providers to report outcomes […]
